Founded in July 2020, Westlake Omics is an AI-empowered micro-world data company. Westlake Omics is aimed at boosting precision medicine and drug research and development by integrating technological innovations in proteomics and multimodal big data. Westlake Omics has now gathered more than 100 highly-qualified talents with diverse backgrounds such as biology, medicine, and AI.
Till now, Westlake Omics has established cooperation with over 100 renowned universities and research institutes, hospitals, and pharmaceutical companies from both at home and abroad and is the owner of a number of national patents and computer software copyrights.
Westlake Omics, a global leader in Al-empowered Proteomics. Mass & Math, improve your life.
Micro-World Discoveries for Macro Health
Assistant Professor & PhD Supervisor, Westlake University
Principal Investigator, Guomics Laboratory of Proteomic Big Data, Westlake University
Director, iMarker Lab, Westlake Laboratory
More in www.guomics.com and www.imarkerlab.com.
Dr. Luonan Chen
Researcher at Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences; Principal Professor at Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences; Executive Director of Key Laboratory of Systems Biology, Chinese Academy of Sciences
Dr. Zhongzhi Luan
The deputy dean of the China-Germany Joint Software Institute of School of Computer Science and Engineering at Beihang University.
Dr. Changzheng Yuan
Research Professor and Doctoral supervisor at Zhejiang University School of Public Health
Ju-Sheng Zheng, Ph.D.
Principal Investigator, Assistant Professor and PhD supervisor